A 66-year-old woman with type 2 diabetes and established ASCVD has HbA1c 60 mmol/mol on metformin. BMI 30, eGFR 65. What is the next agent with proven...

Question

A 66-year-old woman with type 2 diabetes and established ASCVD has HbA1c 60 mmol/mol on metformin. BMI 30, eGFR 65. What is the next agent with proven cardiovascular benefit?

Accepted Answer

Empagliflozin

Answer

Gliclazide

Answer

Sitagliptin

Answer

Acarbose

Answer

NPH insulin

ukmla MCQ (SBA): T2DM with ASCVD

A 66-year-old woman with type 2 diabetes and established ASCVD has HbA1c 60 mmol/mol on metformin. BMI 30, eGFR 65. What is the next agent with proven cardiovascular benefit?